tranScrip Becomes Latest Partner of One Nucleus

Cambridge, UK: 11 May 2021

One Nucleus, the non-for-profit Life Science membership group headquartered in Cambridge exists to support growing Life Science businesses throughout their life cycle as they translate great science into better patient outcomes. This includes facilitating connections between companies and expert development partners. tranScrip, a leading provider of specialist services to support Pharma and biotech companies on product development and life cycle management has become the latest company to join the One Nucleus Partner Programme. The programme is tailor-made to meet the needs of the Partner and One Nucleus members.

Paul Branthwaite, Senior Partner at tranScrip commented, “tranScrip has a successful track record in supporting our clients’ early to late-stage programmes as an external partner or, more usually, embedded within their team. Supporting product development, partnering and growth across global markets, tranScrip maximises the value and minimises the risk, using our expertise and extensive network for the benefit of our clients. Joining the One Nucleus Partner Programme brings further opportunities for tranScrip to contribute to this growing ecosystem, knowledge-sharing and improving connectivity to enable further innovative products to reach patients”.

Tony Jones, CEO of One Nucleus expands further ‘We are delighted to welcome tranScrip, a long-term member of the One Nucleus community, to the One Nucleus Partner Programme given the pivotal role accessing quality advice plays in our sector and the goals of One Nucleus to facilitate the required connections. Having tranScrip engaged to provide such insights for members, as partner sin the Virtual Innovation Centre and contributing our events will bring great value to all concerned.’

Media Contact Information: 

For further information, please contact:

Tony Jones, CEO